Risk management- plan Indehaveren af markedsføringstilladelsen forpligter sig til at udføre forsøg og yderligere pharmacovigilance- aktiviteter.
The MAH must ensure that the system of pharmacovigilance, as described in the July 2007 version, is in place and functioning before and whilst the product is on the market.